ARX-788 well-tolerated in phase I study in Chinese patients with metastatic HER2+ breast cancer Dec. 16, 2019
BET inhibitor JQ1(+) can be repurposed for lymphatic filariasis, new transcriptomics study suggests Dec. 16, 2019
Phase II trials of concizumab show clinical proof of concept for bleeding prevention in hemophilia Dec. 16, 2019
LNC Therapeutics and INRA enter partnership to study anti-inflammatory properties of gut microbiome Dec. 16, 2019
FDA grants accelerated approval to Vyondys 53 for DMD in patients amenable to skipping exon 53 Dec. 13, 2019
Phase II study of TG-4010 combination regimen in advanced NSCLC fails to meet primary endpoint Dec. 13, 2019
RSS